Insider buying
~$36K10K sh @ $3.62
Traded Nov 14, 2024 · filed 5 days later
A Tango Therapeutics director paid $36K out of pocket for Tango Therapeutics shares. It was the first purchase in over a year. Shares held went up 89% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 18, 2024 · Filed Nov 19, 2024
A Tango Therapeutics director paid $38K out of pocket for Tango Therapeutics shares. Shares held went up 47% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$37,800
Shares × reported transaction price
$25K–$100K
+47.1%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
Yes
Compared with 1 earlier confirmed purchase
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
12 days after results of Nov 6, 2024, 56 days before results of Jan 13, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −0.3% | +1.8% | −2.0% |
| 30 days | −23.6% | −0.7% | −22.9% |
| 90 days | −36.9% | +3.6% | −40.5% |
| 180 days | −40.5% | +0.8% | −41.3% |
| 365 days | +115.2% | +12.3% | +102.9% |
Past results only. Not a forecast.
Insider buying
Traded Nov 14, 2024 · filed 5 days later
A Tango Therapeutics director paid $36K out of pocket for Tango Therapeutics shares. It was the first purchase in over a year. Shares held went up 89% with this purchase.
Fund moves
2 tracked managers disclosed the same change for Q3 2024. From a 13F filed Nov 14, 2024 covering holdings at Sep 30, 2024 — a quarter-end snapshot, not a live trade.
Insider selling
Traded Nov 6, 2024 · filed 3 days laterNot reported under a pre-arranged trading plan
A major shareholder of Tango Therapeutics sold $4.9M of Tango Therapeutics shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.